1. Home
  2. Labeler Index
  3. Proficient Rx Lp
  4. 63187-427
  5. Product Images: Valsartan And Hydrochlorothiazide

Product Images Valsartan And Hydrochlorothiazide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 63187-427 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1

This text shows a chart indicating the probability of achieving systolic blood pressure less than 140 mm Hg after eight weeks of treatment with Valsartan and Hydrochlorothiazide, compared to a placebo group. The treatment group had a dose of 320 mg/25 mg of the two medications, while the placebo group did not receive active treatment. The baseline systolic blood pressure for all participants was between 145 and 180 mm Hg.*

63187-427-90 - valhyctz fig11

63187-427-90 - valhyctz fig11

This is a description of the medication Valsartan HCTZ 320mg/12.5mg. It comes in pink colored, oval-shaped, beveled edge, biconvex film-coated tablets. The tablets are available in two quantities, 30 and 90, and have a unique serial number, lot number 00000, and expiration date 00/00/00. Each tablet contains Valsartan USP 320mg and hydrochlorothiazide USP 12.5mg. The medicine is for prescription use only and must be stored at a temperature range of 20 degrees Celsius to 25 degrees Celsius. The medication is manufactured by Aurobindo Pharma Limited, Hyderabad, India, and is relabeled by Proficient Rx LP.*

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2

The figure shows the probability of achieving diastolic blood pressure below 90 mmHg at Week 8, with baseline DBP ranging from 95 to 105 mmHg. There is no other available information in the given text.*

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3

The given text describes a figure (Figure 3) that shows the probability of achieving systolic blood pressure less than 130 mmHg at week 8. The text also mentions the doses of Valsartan and Hydrochlorothiazide used for achieving the desired blood pressure level. The figure plots the baseline SBP starting from 140 until 180 on the x-axis and the probability of achieving SBP <130 mmHg on the y-axis.*

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4

This is the result of a clinical study evaluating the probability of achieving a DBP (diastolic blood pressure) of <80 mmHg at week 8 while using Valsartan and Hydrochlorothiazide with a dosage of 320 mg/25mg. The chart shows that at baseline (starting point), the percentage was at 100% for achieving a DBP of <80 mmHg, and by week 8, the probability decreased to 95%. The study includes a placebo-controlled group for comparison.*

Valsartan Chemical Structure - valhyctz str1

Valsartan Chemical Structure - valhyctz str1

Hydrochlorothiazide Chemical Structure - valhyctz str2

Hydrochlorothiazide Chemical Structure - valhyctz str2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.